Catherine Mathis
Geen lopende functies
Profiel
Catherine Mathis served as Director of Regulatory Affairs at Transgene SA from 1994 to 2014.
She then worked as Senior Director of Regulatory Affairs at Voisin Consulting, Inc. in 2014-2015.
In 2016, she became Vice President of Regulatory Affairs at Sangamo Therapeutics France SAS, and later that year, she became the Chief Operating Officer at ElsaLys Biotech SAS, where she worked until 2019.
Dr. Mathis holds a graduate degree from Université Paris 1 Panthéon-Sorbonne and a doctorate from Université de Paris 5 René Descartes.
Eerdere bekende functies van Catherine Mathis
| Bedrijven | Functie | Einde |
|---|---|---|
| ELSALYS BIOTECH | Operationeel Directeur | 01-02-2019 |
| TXCELL | Algemeen Adviseur | 01-09-2016 |
Voisin Consulting, Inc.
 Voisin Consulting, Inc. Miscellaneous Commercial ServicesCommercial Services Voisin Consulting, Inc. provides product development consulting services. It guides biotechnology, pharmaceutical and medical technology manufacturers throughout product development and commercialization. The company was founded by Emanuelle M. Viosin in 1997 and is headquartered in Cambridge, MA. | Algemeen Adviseur | 01-12-2015 |
| TRANSGENE | Algemeen Adviseur | 01-10-2014 |
Opleiding van Catherine Mathis
| Université Paris 1 Panthéon-Sorbonne | Graduate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Beursgenoteerde bedrijven | 1 |
|---|---|
| TRANSGENE | Health Technology |
| Bedrijven in privébezit | 4 |
|---|---|
| Université de Paris 5 René Descartes | Consumer Services |
Sangamo Therapeutics France SAS
 Sangamo Therapeutics France SAS Miscellaneous Commercial ServicesCommercial Services Sangamo Therapeutics France SAS is a biotechnology company, which engages in developing platforms for T cell immunotherapies for the treatment of severe inflammatory and autoimmune diseases. The company was founded on April 12, 2001, and is headquartered in Valbonne-Sophia Antipolis, France. | Commercial Services |
ElsaLys Biotech SAS
 ElsaLys Biotech SAS Pharmaceuticals: MajorHealth Technology ElsaLys Biotech SAS provides therapeutic monoclonal antibody player services. It involves in cellular events at the core of the pathological process: immune response, angiogenesis, survival, proliferation, adhesion and migration. The company also designs and develops a new generation of antibodies that target tumors and their immune microenvironment. ElsaLys Biotech was founded by Christine Guillen, Thierry Menguy, Vanessa Duong, and Martine Brandt in 2013 and is headquartered in Lyon, France. | Health Technology |
Voisin Consulting, Inc.
Voisin Consulting, Inc. Miscellaneous Commercial ServicesCommercial Services Voisin Consulting, Inc. provides product development consulting services. It guides biotechnology, pharmaceutical and medical technology manufacturers throughout product development and commercialization. The company was founded by Emanuelle M. Viosin in 1997 and is headquartered in Cambridge, MA. | Commercial Services |